These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29778554)

  • 21. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
    Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
    Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
    Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
    Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
    Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
    Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
    Zhang S; Yin Y; Li Q; Zhang C
    Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?
    Errázuriz J; Drakopoulos P; Pening D; Racca A; Romito A; De Munck N; Tournaye H; De Vos M; Blockeel C
    Reprod Biomed Online; 2019 Jun; 38(6):1010-1017. PubMed ID: 30879911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles.
    Mai Z; Liu M; Pan P; Li L; Huang J; Chen X; Yang D
    Front Endocrinol (Lausanne); 2021; 12():724333. PubMed ID: 34650517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative live birth rates according to the number of oocytes retrieved following the "freeze-all" strategy.
    Zhao Z; Shi H; Li J; Zhang Y; Chen C; Guo Y
    Reprod Biol Endocrinol; 2020 Feb; 18(1):14. PubMed ID: 32087702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of follicular output rate on cumulative clinical pregnancy rate and cumulative live birth rate in PCOS patients with different characteristics.
    Jiang R; Cao M; Hao H; Jia R; Chen P; Liu Y; Zhao Z
    Front Endocrinol (Lausanne); 2022; 13():1079502. PubMed ID: 36601009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old.
    Devesa M; Tur R; Rodríguez I; Coroleu B; Martínez F; Polyzos NP
    Hum Reprod; 2018 Nov; 33(11):2010-2017. PubMed ID: 30272168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response.
    Yin H; Jiang H; He R; Wang C; Zhu J; Cao Z
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):201-205. PubMed ID: 30910139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?
    Ortega-Hrepich C; Stoop D; Guzmán L; Van Landuyt L; Tournaye H; Smitz J; De Vos M
    Fertil Steril; 2013 Oct; 100(4):1002-7. PubMed ID: 23850301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
    Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
    Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.
    Chen YH; Xu XH; Wang Q; Zhang SD; Jiang LL; Zhang CL; Ge ZJ
    J Assist Reprod Genet; 2015 Oct; 32(10):1459-67. PubMed ID: 26384107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism.
    Yang W; Yang R; Yang S; Li J; Tu B; Gao C; Wang Y
    Gynecol Endocrinol; 2018 Aug; 34(8):715-718. PubMed ID: 29376451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
    Tu X; You B; Jing M; Lin C; Zhang R
    Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.